Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine Era
Sara de Miguel(Instituto de Salud Carlos III), José Yuste(Instituto de Salud Carlos III), Carmen Ardanuy(Bellvitge University Hospital), Julio Sempere(Instituto de Salud Carlos III), Juan Carlos Sanz(Comunidad de Madrid), Dolores Vicioso(Instituto de Salud Carlos III), Luis García Comas(Comunidad de Madrid), Fernando González‐Camacho(Instituto de Salud Carlos III), Asunción Fenoll(Instituto de Salud Carlos III), Mirian Domenech(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias)
Cited by 113
Related Papers
Biofilm Formation Avoids Complement Immunity and Phagocytosis of Streptococcus pneumoniae
|Infection and Immunity|2013|162
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
|The Lancet Digital Health|2023|157
<i>Streptococcus pneumoniae</i> Resistance to Complement-Mediated Immunity Is Dependent on the Capsular Serotype
|Infection and Immunity|2009|117
Impaired Opsonization with C3b and Phagocytosis of<i>Streptococcus pneumoniae</i>in Sera from Subjects with Defects in the Classical Complement Pathway
|Infection and Immunity|2008|110
Serum Amyloid P Aids Complement-Mediated Immunity to Streptococcus pneumoniae
|PLoS Pathogens|2007|106